Modulation of pulmonary dendritic cell function during mycobacterial infection

Area of Science:

• Immunology
• Infectious Diseases
• Cell Biology

Background:

• Pulmonary mycobacterial infections, like tuberculosis, involve complex immune responses in the lungs.
• Naïve CD4(+) T-cell activation is crucial for adaptive immunity against intracellular pathogens.
• Dendritic cells (DCs) are key antigen-presenting cells that bridge innate and adaptive immunity.

Purpose of the Study:

• To investigate the role of chemokine receptor CCR7 and its ligands in lung CD11c(+) dendritic cell (DC) function during Mycobacterium bovis bacillus Calmette-Guérin (BCG) infection.
• To understand how DCs in the lung activate naïve CD4(+) T cells in the context of mycobacterial infection.

Main Methods:

• Mice were infected with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
• Lung CD11c(+) dendritic cells (DCs) were isolated and analyzed for maturation markers (MHC-II) and chemokine receptor (CCR7) expression.
• Gene expression of CCR7 ligands (CCL19, CCL21) was assessed.
• The ability of lung DCs to activate ovalbumin (OVA)-specific naïve CD4(+) T cells was evaluated in vitro.

Main Results:

• BCG infection led to the accumulation and maturation of lung DCs, with increased MHC-II expression.
• CCR7 expression on lung DCs remained comparable between infected and uninfected mice.
• CCL19 gene expression progressively increased during BCG infection in a MyD88-dependent manner.
• Lung DCs from BCG-infected mice showed enhanced activation of naïve CD4(+) T cells compared to controls.
• DCs at peak infection exhibited slightly reduced chemotaxis and T-cell activation capacity compared to late-stage infection.

Conclusions:

• Sustained inflammation and CCL19 expression during BCG infection promote the recruitment, activation, and retention of lung DCs.
• These lung-resident DCs are capable of activating naïve CD4(+) T cells in situ, contributing to the immune response.
• The findings highlight the dynamic role of DCs in pulmonary mycobacterial infections.